Market Overview

UPDATE: KeyBanc Capital Markets Initiates Eastman Chemical at Buy on Specialty Focus

Share:
Related EMN
CLSA Downgrades Eastman Chemical To Underperform
Benzinga's Top Downgrades
Portfolio Changes For The First Quarter Of 2015 (Seeking Alpha)

KeyBanc Capital Markets initiated coverage on Eastman Chemical (NYSE: EMN) with a Buy rating and a $74 price target.

KeyBanc Capital Markets said, "We continue to favor investment stories within the chemical sector that have made meaningful portfolio changes over the years to move into more “specialty businesses,” supporting steady earnings growth and improved margins profiles. We believe a series of acquisitions and divestitures have positioned EMN to post steadier earnings growth through 2015E. We see a good finish to 2012E and EMN's Investor Day on December 12, 2012 as near-term catalysts for the stock as the long-term growth potential for the new EMN is unveiled."

Eastman Chemical closed at $60.05 on Monday.

Latest Ratings for EMN

DateFirmActionFromTo
Mar 2015CLSADowngradesOutperformUnderperform
Feb 2015BarclaysMaintainsEqual-weight
Feb 2015JP MorganMaintainsNeutral

View More Analyst Ratings for EMN
View the Latest Analyst Ratings

Posted-In: KeyBanc Capital MarketsAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (EMN)

Around the Web, We're Loving...